What is the recommended dilution and dosing regimen for intravenous N‑acetylcysteine (NAC) in adult patients with acute liver failure?

NAC Dilution and Dosing Protocol for Acute Liver Failure

For intravenous N-acetylcysteine in acute liver failure, use the FDA-approved 21-hour three-bag regimen: 150 mg/kg loading dose over 15 minutes, followed by 50 mg/kg over 4 hours, then 100 mg/kg over 16 hours (total 300 mg/kg), with mandatory dilution in sterile water, 0.45% saline, or D5W prior to administration. 1

Dilution Requirements

NAC must be diluted before intravenous administration because the concentrated solution is hyperosmolar (2600 mOsmol/L) and cannot be given undiluted. 1

Acceptable Diluents

• Sterile water for injection
• 0.45% sodium chloride (half-normal saline)
• 5% dextrose in water (D5W) 1

Osmolarity Considerations by Concentration

The final osmolarity varies based on diluent choice and NAC concentration:

• 7 mg/mL NAC concentration:

  • Sterile water: 91 mOsmol/L (adjust to ≥150 mOsmol/L in pediatrics)
  • Half-normal saline: 245 mOsmol/L
  • D5W: 343 mOsmol/L 1

• 24 mg/mL NAC concentration:

  • Sterile water: 312 mOsmol/L
  • Half-normal saline: 466 mOsmol/L
  • D5W: 564 mOsmol/L 1

Standard Three-Bag Dosing Protocol

Loading Dose (Bag 1)

• 150 mg/kg diluted in appropriate volume
• Infuse over 15 minutes 2, 1

Second Dose (Bag 2)

• 50 mg/kg diluted in appropriate volume
• Infuse over 4 hours 2, 1

Third Dose (Bag 3)

• 100 mg/kg diluted in appropriate volume
• Infuse over 16 hours 2, 1

Total dose: 300 mg/kg over 21 hours 2, 1

When to Extend Beyond 21 Hours

Continue NAC infusion beyond the standard 21-hour protocol if any of the following persist after completion:

• Detectable acetaminophen levels remain
• AST/ALT continue rising
• INR remains elevated
• Suspected massive overdose
• Concomitant ingestion of other substances
• Pre-existing liver disease 1

Extended dosing regimen: 150 mg/kg in 500 mL D5W infused over 24 hours, continuing until two consecutive normal INRs are obtained. 3 For non-acetaminophen ALF, extended duration beyond 72 hours has shown significantly higher transplant-free survival (76.9% vs 41.4%) compared to standard duration. 4

Oral Alternative (When IV Unavailable)

Oral NAC dosing:

• Loading dose: 140 mg/kg orally or via nasogastric tube (diluted to 5% solution)
• Maintenance: 70 mg/kg every 4 hours for 17 additional doses 2

Critical caveat: Oral route is often contraindicated in ALF patients with active GI bleeding, worsening mental status, or encephalopathy. 2 The intravenous route is strongly preferred in ALF.

Indications by Etiology

Acetaminophen-Induced ALF

Begin NAC immediately when any of the following are present:

• Known or suspected acetaminophen overdose
• Toxic serum acetaminophen levels (even if ingestion was remote)
• Rising aminotransferases suggesting evolving injury
• Clinical context unclear regarding acetaminophen exposure 5, 2

Do not wait for acetaminophen level results before starting NAC. 2 Very high aminotransferases (>3,500 IU/L) are highly correlated with acetaminophen poisoning and should prompt NAC initiation even without historical evidence. 5

Non-Acetaminophen ALF

NAC is recommended for all etiologies of acute liver failure based on strong evidence showing:

• Overall survival: 76% with NAC vs 59% without (OR 2.30, p<0.0001)
• Post-transplant survival: 85.7% vs 71.4% (OR 2.44, p=0.03)
• Reduced progression to severe encephalopathy (grade III-IV): 40% vs 68% (p=0.047)
• Lower vasopressor requirement: 48% vs 80% (p=0.018) 2

However, benefits are confined to early-stage patients (coma grades I-II), with transplant-free survival of 52% vs 30% in this subgroup. 6 Patients with advanced coma grades (III-IV) show no benefit and typically require emergency transplantation. 6

Preparation and Storage

• Visually inspect for particulate matter and discoloration before administration
• Color ranges from colorless to slight pink or purple after stopper puncture (does not affect quality)
• Diluted solution stable for 24 hours at room temperature
• Discard unused portion
• Never use previously opened vials for IV administration 1

Monitoring Requirements

Monitor throughout treatment:

• Hepatic enzymes (AST, ALT)
• Bilirubin
• INR
• Creatinine and BUN
• Blood glucose
• Electrolytes
• Arterial lactate 2, 1

Check after final maintenance dose: If acetaminophen levels detectable or ALT/AST rising or INR elevated, continue dosing and contact poison center (1-800-222-1222) or special assistance line (1-800-525-6115). 1

Hypersensitivity Management

Anaphylactoid reactions occur in 30-60 minutes after infusion start, presenting with rash, hypotension, wheezing, dyspnea, or facial flushing. 2, 1

Management algorithm:

1. Immediately stop the infusion if severe reaction occurs
2. Administer antihistamines
3. Give epinephrine for bronchospasm
4. For mild flushing/erythema alone: may continue infusion with close monitoring 2, 1

Special caution: Use with extreme caution in asthma patients; one asthmatic patient died from bronchospasm after IV NAC. 1 Monitor asthmatics closely throughout therapy.

Activated Charcoal Timing

Give activated charcoal (1 g/kg orally) if presentation occurs ≤4 hours after ingestion, administered just prior to starting NAC. 5, 2 Charcoal may provide benefit up to 3-4 hours post-ingestion and does not reduce NAC efficacy. 5

Critical Pitfalls to Avoid

• Never delay NAC while awaiting diagnostic confirmation in suspected acetaminophen overdose 2
• Do not use the Rumack-Matthew nomogram for repeated supratherapeutic ingestions (RSI); different risk stratification applies 1
• Do not discontinue NAC prematurely in massive overdose or when liver function tests remain abnormal 1
• Ensure proper dilution to avoid hyperosmolar complications, especially in pediatric patients (maintain osmolarity ≥150 mOsmol/L) 1